当前位置：首页 > 文献互助 > 互助详情

1197 The MAIT engager platform: rapid generation of several MAIT T-cell engagers with significantly improved safety profile and large therapeutic window复制

用户psdjqfAF58T4 2小时前 9 10 待确认 帖子自动结束时间: 2026-04-05 13:24:32

1. 请及时下载文件确认是否正确, 系统将在 2026-04-07 14:23:31 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

上一篇：Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS

下一篇：Taking Advantage of Activation Potential Coincidence to Unlock Stable Direct Seawater Splitting

互助时间线

2026-03-31 14:23:31 [上传文件]

jodie0105上传了文件(pdf 41.97 KB), 求助状态变成 待确认

2026-03-31 13:24:32 [发起求助]

最新发布的求助

Oxyanion-Coordinated Co-Based Catalysts for Optimized Hydrogen Evolution: The Feedback of Adsorbed Anions to the Catalytic Activity and Mechanism 4分钟前
Myasthenia Gravis – An Updated Review 10分钟前
Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy 11分钟前
Surface-Bound Formate Oxyanions Destabilize Hydration Layers to Pave OH– Transport Pathways for Oxygen Evolution 16分钟前
Graves’ disease: a new era of pathophysiology-guided therapeutics 16分钟前
Emerging Therapeutics in Rheumatoid Arthritis 20分钟前
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials 29分钟前
RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079) 35分钟前
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants 39分钟前
Recent progress on glucose dehydrogenase: multifaceted applications in industrial biocatalysis, cofactor regeneration, glucose sensors, and biofuel cells 43分钟前
Unveiling coordination transformation for dynamically enhanced hydrogen evolution catalysis 45分钟前
VNAR: shark single-domain antibodies for the new era of medical biotechnology 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com